Author: Gungil

Quite a long time ago, during my Ph.D. studies, the process of generating new antibodies to study novel molecules typically began with producing proteins for immunization. This involved creating expression vectors for the full-length protein, extracellular domains, or specific regions, or synthesizing peptide fragments. The proteins were then used to immunize mice, rabbits, or ferrets, with repeated boosts to obtain sera containing polyclonal antibodies. Next, B cell hybridomas were generated, and individual hybridoma cell lines were established. These lines were screened using techniques such as Western blot, immunoprecipitation, and other immunoassays to identify antibodies that were effective for the intended research purpose.

Currently, we observed antibody based drugs such as anti-VEGF and anti-TNF. So I talked about antibody libraries today.

Discovering the Right Antibody: How Antibody Libraries Speed Up the Search

To find an antibody that targets a specific antigen, scientists must sort through billions of possibilities to find the best match. That might sound impossible—but thanks to antibody libraries, this search is now faster and more efficient.

Also some antigens, particularly secreted or membrane proteins, are very difficult to produce antibodies because of the high similarity between the human protein and the immunized animals’ own (self vs non-self problem). Using a library can be a good starting point to identify antibodies.

What Are Antibody Libraries?

An antibody library is a large collection of antibodies with diverse binding properties. Researchers can screen these libraries to find antibodies that tightly bind to a chosen target, such as a virus protein or disease marker.

There are three main types of antibody libraries:

1. Immune libraries – made from individuals who have already been exposed to the antigen.
   • Pros: Naturally evolved, high-affinity antibodies.
     • Cons: Limited to one specific antigen.
2. Naive libraries – made from donors who have not been exposed to the antigen.
   • Pros: Can be used to target many different antigens.
   • Cons: Usually produce antibodies with moderate affinity.
3. Synthetic and semi-synthetic libraries – built entirely in the lab using DNA synthesis.
   • Pros: Fully customizable, no need for donors or immunization.
   • Cons: Require advanced design and synthesis tools.

Are there mice that produce human antibodies?

Yes

RenMab and RenLite are humanized mouse platforms developed by Biocytogen for therapeutic antibody discovery. Both generate fully human antibodies, but they differ in design and applications. RenMab mice have their heavy chain (VH) and light chain (VL) loci fully replaced with human sequences, providing complete diversity in both chains. This makes RenMab ideal for discovering monospecific, high-affinity antibodies against a wide range of targets. B cells from immunized RenMab mice produce unique VH and VL combinations, resulting in antibodies with diverse antigen-binding sites.

RenLite, in contrast, is optimized for bispecific antibody discovery. It has a fully human heavy chain repertoire but uses a single common kappa (κ) light chain for all B cells. Each antibody arm still has six CDRs (three from VH, three from the shared VL), but the heavy chain drives binding diversity. The common light chain ensures correct heavy/light chain pairing when combining two arms into a bispecific antibody, reducing mispairing and simplifying manufacturing. However, this is a different method from CrossMab.

You might visit and see the scientific papers: 
Christopher Thomas Schott, 2007 
Nils Lonberg and Dennis Huszar, 1995
Kazuto Shimmoya et al., 2004

How Are Antibody Libraries Screened?

Once a library is created, scientists use display technologies to “show” the antibodies to their target antigens in a process called biopanning. This helps identify the strongest binders.

The most common display systems include

• Phage display: antibodies are shown on the surface of viruses that infect bacteria.
• Yeast display: antibodies are presented on yeast cells, allowing researchers to work with full-length antibodies (closer to therapeutic ones).
  

Guide to Antibody Libraries | Biocompare.com